<?xml version="1.0" encoding="UTF-8"?>
<p id="JVEv5-para-0037">The overview of the HBV replication cycle highlighted specific targets that may be considered for developing curative therapy. Efficient cccDNA disabling, which would eliminate the template for virus production is a focus of many HBV researchers, and, although achieving this crucial goal remains challenging, the field is poised to see significant progress in the near future.</p>
